KALYDECO 150 mg, comprimé pelliculé — plaquette(s) (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930159484
  • CIP7 3015948
  • CIS 65036318
  • Registration number EU/1/12/782

What the source publishes

Holder
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Active ingredients
IVACAFTOR
Form
comprimé pelliculé
Package
plaquette(s) (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2012-07-23
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930159484
{
  "cis": "65036318",
  "cip7": "3015948",
  "form": "comprimé pelliculé",
  "name": "KALYDECO 150 mg, comprimé pelliculé — plaquette(s) (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)",
  "cip13": "3400930159484",
  "holder": "VERTEX PHARMACEUTICALS (EUROPE) LIMITED",
  "routes": [
    "orale"
  ],
  "holders": [
    "VERTEX PHARMACEUTICALS (EUROPE) LIMITED"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "5005.75",
  "authorisedOn": "2012-07-23",
  "compositions": [
    {
      "name": "IVACAFTOR",
      "nature": "SA",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "91389",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "5004.73",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "KALYDECO 150 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) (ACLAR RX) polytrifluorochloroéthylène aluminium de 28 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2021-07-06",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "IVACAFTOR"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière semestrielle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Mucoviscidose chez les personnes âgés de 6 ans et plus, porteuses de certaines caractéristiques génétiques précises. ; JOURNAL OFFICIEL ; 04/02/20",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/12/782",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930159484"